Avay Biosciences is developing 3D bioprinting technology in India, creating systems capable of replicating human tissue. The technology is being applied in areas such as drug testing, with potential future uses including organ printing.

Supported by government initiatives and experiencing rapid growth, the company says it is working to reduce reliance on animal testing and expand its international presence.

This text summary was created by AI from the original DW script. It was edited by a journalist before publication.